Autologous Cervical Cancer-specific Engineered Immune Effector Cells

**Semantic type:** Cell|Pharmacologic Substance

**Definition:** A preparation of autologous immune effector cells genetically modified to target a not yet disclosed cervical cancer-specific tumor-associated antigen (TAA), with potential immunomodulating and antineoplastic activities. After isolation, transduction, expansion in culture, and reintroduction into the patient, the autologous cervical cancer-specific engineered immune effector (CC-EIE) cells bind to and induce selective toxicity in tumor cells expressing the TAA.

**Synonyms:** - Autologous CC-EIE Cells - Autologous CC-EIEs